Skip to main content
USNA logo

USNA · Usana Health Sciences Inc

Track USNA — free
$14.85 +0.03 (+0.20%) At close · Oct 5
Market Cap
$267.91M
Shares
18.48M
Volume · Oct 5 163.73K Avg daily vol (3M) 183.22K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$14.85 Open$14.77 Day$14.57–14.95 52W close$12.86–26.58 Avg vol 30d197K Short int755K · 4.1% float · 3.4d Short vol39% Last earningsAug 5, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 13

Up next

Next earnings call
Oct 29, 2026 Est · unconfirmed · in 3 wks
filed Aug 13, 2026
call held Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$913.36M
Trailing 12 months
Net income (TTM)
−$22.16M
Trailing 12 months
Revenue growth YoY
-5.3%
Year over year
Operating margin
-0.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
5.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$168.56M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.3%
Year over year · fewer shares
Price change (1Y)
-46.0%
Trailing year
Short interest
4.1%
Latest settlement · 3.4 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −20%
below
Price vs 50-day avg −4%
below
RSI (14) 50
neutral
MACD trend Positive
52-week position 15%
near low
Momentum
relative strength
Very Weak
1-month return −1%
trailing
6-month return −20%
trailing
YTD return −24%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $15 › 200d $19 — 200d above 50d
Institutional flow Distributing
2 of 137 funds reported for Sep 30 · net -163 sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.08% of float · ▲ +16.9% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
137 holders — mid 3-yr range
Squeeze score 64
elevated · 0–100
Fundamentals
Strong
Revenue growth −11%
Y/Y
Gross margin 68%
expanding
EPS growth −74%
Y/Y
Free cash flow $8.5M
Buyback $34.0M
remaining
Quant / Vol
risk profile
Very High
Volatility 58%
annualized · 1-yr
Max drawdown −53%
past year
ATR 3.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 4
Latest guidance · from the 8-K filed Aug 4, 2026
Fiscal Year 2026
Hiya net sales Initiated $125M
Rise Wellness net sales Initiated $35M
Consolidated net sales Initiated $910M
prior FY $925.26M midpoint −1.6% Y/Y
Diluted EPS Initiated $-0.61
prior FY $0.58 midpoint −205.2% Y/Y
Adjusted diluted EPS Initiated $0.76
Adjusted EBITDA Initiated $87M
fiscal year 2026
Consolidated income taxes Initiated $30M
Guided vs delivered · last 4 settled
Consolidated Net Sales Fiscal Year 2024
guided $850M – $920M
$854.5M In line
Diluted EPS fiscal year 2024
guided $2.40 – $3.00
$2.19 Miss −18.9%
Consolidated Net Sales fiscal year 2023
guided $900M – $920M
$921.01M Beat +1.2%
Diluted EPS fiscal year 2023
guided $2.80 – $3.05
$3.30 Beat +12.8%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−20% Bearish
Price vs 50-day avg
−4% Neutral
RSI (14)
50 Neutral
MACD trend
Positive Bullish
52-week position
15% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $15 › 200d $19 — 200d above 50d
Institutional flow Distributing
2 of 137 funds reported for Sep 30 · net -163 sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.08% of float · ▲ +16.9% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
137 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $13 Now $15 · 15% Range high $27
vs 200-day avg -20% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
USNA
Usana Health Sciences Inc
this stock
$267.91M -24.4% -10.8% — 4.1%
JBS
Jbs N.V.
$38.06B -17.5% — — 1.2%
KHC
Kraft Heinz Co
$28.02B -9.9% -0.1% — 7.9%
GIS
General Mills Inc
$17.99B -31.9% +4.1% — 8.4%
SJM
J M SMUCKER Co
$12.93B +18.8% +3.7% — 4.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
138
% held
61.8%
Reported
2 of 137
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
189
View
Short & Settlement
Short Interest Rising
Shares short
754.7K
Days to cover
3.4d
Change
+109.0K sh
View
Short Volume
Short vol %
39%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
1.3K
Value
$18.2K
As of
Sep 4, 2026
View
Off-Exchange
Off-exchange %
50.6%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$925.3M
Net income (FY)
$10.8M
EPS diluted
$0.58
View
Buybacks
Authorized
$150.0M
Remaining
$34.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 5, 2026
This year
12
View
Proposed Sales
Value
$97.3K
Shares
5.0K
Filed
Jun 16, 2026
View
Earnings & Events
Webcasts
Last webcast
Aug 5, 2026
View

Performance

5D 20D 120D MTD YTD
USNA +0.2% -0.7% -19.8% +2.6% -24.4%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY -1.0% -1.3% -31.3% +1.0% -38.0%

Capital returns

Buyback program · as of Jul 4, 2026
Authorized
$150.00M
Spent (derived)
$116.03M
Remaining
$33.97M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 896264 CUSIP 90328M107 13F (30d) 3 filings 3 filers Visit website Investor relations